IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.2824
-0.0076 (-2.62%)
Apr 2, 2025, 4:00 PM EST - Market closed

IGC Pharma Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2015 - 2019
Market Capitalization
232618488119
Upgrade
Market Cap Growth
45.77%46.64%-62.80%-40.34%321.48%-76.60%
Upgrade
Enterprise Value
23251437794
Upgrade
Last Close Price
0.290.400.340.951.790.49
Upgrade
Forward PE
-4.354.354.354.354.35
Upgrade
PS Ratio
16.8019.6519.78122.0390.434.73
Upgrade
PB Ratio
3.573.611.212.032.480.73
Upgrade
P/TBV Ratio
5.934.631.312.112.510.73
Upgrade
PEG Ratio
2.262.262.262.262.262.26
Upgrade
EV/Sales Ratio
18.2518.9114.8293.5788.351.01
Upgrade
Debt / Equity Ratio
0.040.050.030.030.030.02
Upgrade
Asset Turnover
0.120.100.040.010.030.13
Upgrade
Inventory Turnover
0.360.290.150.040.141.76
Upgrade
Quick Ratio
0.210.551.834.536.276.41
Upgrade
Current Ratio
1.151.583.416.199.939.13
Upgrade
Return on Equity (ROE)
-115.06%-116.95%-59.30%-52.97%-29.70%-24.34%
Upgrade
Return on Assets (ROA)
-54.70%-45.23%-32.86%-29.10%-16.81%-13.52%
Upgrade
Return on Capital (ROIC)
-69.70%-53.12%-36.25%-31.25%-17.87%-14.12%
Upgrade
Earnings Yield
-38.71%-49.20%-63.85%-31.00%-10.85%-37.97%
Upgrade
FCF Yield
-20.65%-20.20%-40.83%-15.89%-15.11%-67.82%
Upgrade
Buyback Yield / Dilution
-29.68%-11.91%-5.17%-19.13%-6.26%-11.57%
Upgrade
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q